Compartment Psoas Block Efficacy and Safety
Femur Fracture
About this trial
This is an interventional treatment trial for Femur Fracture focused on measuring сompartment psoas block, femur fracture.
Eligibility Criteria
Inclusion Criteria:
-proximal femur fracture
Exclusion Criteria:
- pregnancy and lactation
- history of opiate addiction
- traumatic brain injury
- acute cerebrovascular accident
- chronic heart failure (New York Heart Association Functional Classification, NYHA, class III-IV)
- respiratory failure
- renal failure with decreased creatinine clearance less than 30 ml / min / 1.73 m2
- hepatic insufficiency class C according to Child-Pugh).
Sites / Locations
- Bogomolets NMU
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
No Intervention
Group 1
Group 2
Group 3
Patients in group 1 underwent catheterization of the lumbar plexus from the posterior access on admission to the hospital and began analgesia with bupivacaine 0.125% 6-8 ml / h. Intraoperative anaesthesia was provided with a bupivacaine bolus of 0.5% 200 mg in a lumbar catheter and a sciatic nerve block with 1.5% 450 mg of lidocaine. Postoperative analgesia was provided by an elongated lumbar plexus block with bupivacaine 0.125% 6-8 ml / h.
Patients in group 2 underwent intraoperative spinal anaesthesia at the level of L3-L4 with hyperbaric bupivacaine at a dose of 10-15 mg.
Group 3 patients underwent general inhalation anaesthesia with sevoflurane with a constant infusion of fentanyl for analgesia.